openPR Logo
Press release

COVID-19 Impact on Aneurysmal Subarachnoid Hemorrhage Drugs Market Which Expected to Reach $206,675 Thousand by 2023

06-18-2020 08:29 PM CET | Health & Medicine

Press release from: Allied Market Research

Aneurysmal Subarachnoid Hemorrhage Drugs Market

Aneurysmal Subarachnoid Hemorrhage Drugs Market

Global aneurysmal subarachnoid hemorrhage drugs market was valued at $160,269 thousand in 2016, and is estimated to reach $206,675 thousand by 2023, growing at a CAGR of 3.6% from 2017 to 2023.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4602

Aneurysmal subarachnoid hemorrhage is a kind of stroke, which is caused by bleeding in the subarachnoid space of the brain. The major reasons for aneurysmal subarachnoid hemorrhage include brain aneurysm, arteriovenous malformation, or head injury. Change in lifestyles such as smoking and alcohol consumption increase the risk for aSAH, as well as rise in geriatric population are the major factors that contribute to the growth of the market.

Moreover, increase in prevalence of hypertension, and stroke further boost the market growth. However, the associated side effects of the drugs are expected to impede the market growth. In addition, a need to create awareness about the optimal diagnosis and treatment of aneurysmal subarachnoid hemorrhage provide lucrative opportunities for the market growth.
.
Opioid analgesics generated the maximum revenue, accounting for more than two-fifths share of the global aneurysmal subarachnoid hemorrhage drugs market in 2016. The calcium channel blockers segment is expected to witness the highest CAGR of 4.5% during the forecast period, owing to their ability to reduce the risk of brain damage.

Key Findings of the Aneurysmal Subarachnoid Hemorrhage Drugs Market:
• The opioid analgesics segment is expected to grow at a significant CAGR of 2.6% during the forecast period.
• The anticonvulsants segment contributed nearly one-fourth share of the global aneurysmal subarachnoid hemorrhage drugs market in 2016.
• The stool softeners segment is projected to grow at a significant CAGR of 4.2% during the forecast period.
• Germany and France are the major shareholders, which collectively accounted for more than one-third share of the European aneurysmal subarachnoid hemorrhage drugs market in 2016.
• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific aneurysmal subarachnoid hemorrhage drugs market in 2016.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4602

The Asia-Pacific market is projected to grow at the highest CAGR of 5.5% during the forecast period, owing to rise in awareness about the treatment of aneurysmal subarachnoid hemorrhage in the healthcare industry and surge in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs.

The major companies profiled in the report are Arbor Pharmaceuticals Inc., Edge Therapeutics, Inc., Johnson & Johnson (Actelion Pharmaceuticals Ltd.), Mylan N.V., Orexo AB, Pfizer Inc., Purdue Pharma L.P., Pharmaxis, Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. (Cephalon, Inc.)

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COVID-19 Impact on Aneurysmal Subarachnoid Hemorrhage Drugs Market Which Expected to Reach $206,675 Thousand by 2023 here

News-ID: 2077156 • Views: 167

More Releases from Allied Market Research

Europe Cable Management Market 2020-2027: Latest COVID-19 Impact Analysis, Marke …
Allied Market Research published a new report, titled, "Europe Cable Management Market By Type (Distribution Board, Junction Box, Conduits, Trunking, Cable Tray, Bus Bar, and Others) and End User (IT & Telecom, Commercial Construction, Healthcare, Energy, Manufacturing & Automation, Marine, Mining, and Others) - Europe Opportunity Analysis and Industry Forecast, 2020-2027" The report provides a detailed study of the global Europe cable management market covering a number of important aspects such
Asia-Pacific ATM Market By 2027: Market Share, Emerging Trends, Top Impacting Fa …
Allied Market Research published a new report, titled, "Asia-Pacific ATM Market By Solutions (ON site ATMs, Off site ATMs, Work site ATMs, Mobile ATMs, Managed services) and by Type (Conventional ATM, Brown label ATM, White label ATM, Smart ATM, Cash dispenser) - Opportunity Analysis and Industry Forecast, 2020-2027" The report provides a detailed study of the global Asia-Pacific ATM market covering a number of important aspects such as current market scenario,
Sound Level Meters Market 2020–2027: Market Share, Current Trends, Top Impacti …
Allied Market Research published a new report, titled, "Sound Level Meters Market By Type (Ordinary Sound Level Meters and Precision Sound Level Meters), and Application (Factories & Enterprises, Environment Protection, Transportation, R&D, and Others) - Global Opportunity Analysis & Industry Forecast, 2020-2027". The report provides a detailed study of the global sound level meters market covering a number of important aspects such as current market scenario, estimates, top investment pockets, recent
At 7.4% CAGR, Flexible Electronics Market Estimated to Attain $42.48 Billion By …
Allied Market Research published a new report, titled, "Flexible Electronics Market By Component (Flexible Display [OLED, E-paper, and LCD], Flexible Battery, Flexible Sensor [Bio Sensors, CMOS Hybrid Sensors, Photo Detectors, Piezo Resistive, and Others], Flexible Memory, and Flexible Photovoltaics) and Application (Consumer Electronics, Automotive, Medical & Healthcare, Energy & Power, Aerospace & Defense, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027". The report provides a detailed study of the global

All 5 Releases


More Releases for Aneurysmal

Aneurysmal Subarachnoid Hemorrhage Market Prospective Growth 2025 - Arbor Pharma …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market Preventing challenges complications 20 …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Top Factors Driving the Global Aneurysmal Subarachnoid Hemorrhage Drugs Market
HTF MI recently introduced Global Aneurysmal Subarachnoid Hemorrhage Drugs Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. At present, the market is developing its presence and some of the key players from the complete study are Arbor Pharmaceuticals Inc. (US), Edge Therapeutics, Inc. (US), Johnson & Johnson (Actelion Pharmaceuticals Ltd.) (US), Mylan N.V. (US), Orexo AB (Sweden), Pfizer
Aneurysmal Subarachnoid Hemorrhage Market witness lethargic growth 2025
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market Dynamic Business Environment during 20 …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market - Predicted Analysis and Forecast 2017 …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the